Petros Pharmaceuticals Inc (NASDAQ:PTPI) is a pharmaceutical company focusing on men’s health therapeutics. In an interview with Benzinga, Fady Boctor, the President and Chief Commercial Officer of Petros Pharmaceuticals, said the company aims to expand access of key prescription pharmaceuticals as over-the-counter (OTC) treatment options. Boctor added that Petros is a pure play in the Rx-to-OTC self-care market, focused on bringing its current lead erectile dysfunction (ED) therapeutic OTC whil
London had regained its crown as Europe’s biggest stock market, just two years after losing that status to Paris. French stocks have suffered from the shock election called by President Emmanuel Macron last week which hit bank shares in particular. Meanwhile, London shares after a long period in the doldrums are showing renewed signs of life with bankers saying clients are looking to get deals moving again, leading to floats and share price boosts.
‘I’m grateful for every single bit of it,’ actor said of social media furore